Literature DB >> 31668481

Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy.

Sean Loudin1, Jessica Haas2, Mary Payne3, Marianna Footo Linz4, Dana Meaney-Delman5, Margaret A Honein5, Amy Saunders6.   

Abstract

Neonatal withdrawal can be difficult to treat in infants with co-exposure to opiates and gabapentin. Because maternal self-report can underestimate exposures, we evaluated the effect of universal toxicology screening for gabapentin. Identification of co-exposure to opiates and gabapentin increased after implementation of toxicology screening, with implications for improved neonatal care.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31668481      PMCID： PMC7503060          DOI： 10.1016/j.jpeds.2019.09.029

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  7 in total

Review 1.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

2.  An Atypical Withdrawal Syndrome in Neonates Prenatally Exposed to Gabapentin and Opioids.

Authors:  Sean Loudin; Sara Murray; Leesa Prunty; Todd Davies; Joseph Evans; Joseph Werthammer
Journal:  J Pediatr       Date:  2016-11-23       Impact factor: 4.406

Review 3.  Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.

Authors:  Margaret A Honein; Coleen Boyle; Robert R Redfield
Journal:  Pediatrics       Date:  2019-01-17       Impact factor: 7.124

4.  Appropriate Use of Drug Testing in Clinical Addiction Medicine.

Authors:  Margaret Jarvis; Jessica Williams; Matthew Hurford; Dawn Lindsay; Piper Lincoln; Leila Giles; Peter Luongo; Taleen Safarian
Journal:  J Addict Med       Date:  2017 May/Jun       Impact factor: 3.702

5.  Accuracy of five self-report screening instruments for substance use in pregnancy.

Authors:  Steven J Ondersma; Grace Chang; Tiffany Blake-Lamb; Kathryn Gilstad-Hayden; John Orav; Jessica R Beatty; Gregory L Goyert; Kimberly A Yonkers
Journal:  Addiction       Date:  2019-06-19       Impact factor: 6.526

Review 6.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

7.  Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.

Authors:  Krista F Huybrechts; Brian T Bateman; Rishi J Desai; Sonia Hernandez-Diaz; Kathryn Rough; Helen Mogun; Leslie S Kerzner; Jonathan M Davis; Megan Stover; Devan Bartels; Jennifer Cottral; Elisabetta Patorno
Journal:  BMJ       Date:  2017-08-02
  7 in total
  1 in total

1.  Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons.

Authors:  Walaa F Alsanie; Sherin Abdelrahman; Majid Alhomrani; Ahmed Gaber; Hamza Habeeballah; Heba A Alkhatabi; Raed I Felimban; Charlotte A E Hauser; Hossam H Tayeb; Abdulhakeem S Alamri; Bassem M Raafat; Sirajudheen Anwar; Khaled A Alswat; Yusuf S Althobaiti; Yousif A Asiri
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.